The Chlordiazepoxide Hydrochloride C, cataloged under National Stock Number 6505-00-059-9018, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Hoffmann-La Roche Inc.. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 7 commercial cross-references from 5 manufacturers, enabling identification through both NSN and commercial part number lookups. 4 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-059-9018 |
| Primary Part Number | 76212 |
| Item Name | Chlordiazepoxide Hydrochloride C |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Hoffmann-La Roche Inc. |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT |
| Protective Storage Feature | SECURITY STORAGE |
| Capsule Primary Container Content Quantity | 500.000 |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| 76212 PRIMARY | Hoffmann-La Roche Inc. (USA) |
| LIBRIUM | Hoffmann-La Roche Inc. (USA) |
| NDC00143-3090-05 | Hikma Pharmaceuticals Usa Inc. (USA) |
| NDC00003-0718-60 | Squibb E R and Sons Inc World Hq (USA) |
| NDC00182-0977-05 PRIMARY | Goldline Laboratories Government Sales Div (USA) |
| NDC00140-0001-14 PRIMARY | Hoffmann-La Roche Inc. (USA) |
| NDC00003-0718-60 PRIMARY | Bracco Diagnostics Inc. (USA) |
NSN 6505-00-059-9018 is a Chlordiazepoxide Hydrochloride C, manufactured by Hoffmann-La Roche Inc., classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-00-059-9018 has 7 cross-referenced part numbers: 76212 (Hoffmann-La Roche Inc.), LIBRIUM (Hoffmann-La Roche Inc.), NDC00143-3090-05 (Hikma Pharmaceuticals Usa Inc.), NDC00003-0718-60 (Squibb E R and Sons Inc World Hq), NDC00182-0977-05 (Goldline Laboratories Government Sales Div) and 2 more.
There are 4 known substitutes for 6505-00-059-9018: 6505-00-059-9017, 5930-00-272-1376, 5365-00-510-7038 and 1 more. Verify interchangeability with system specifications before substitution.
Key specifications for 76212: Primary Container Type: BOTTLE; Active Medicament Medicinal Strength: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT; Protective Storage Feature: SECURITY STORAGE; Capsule Primary Container Content Quantity: 500.000. 5 total characteristics are documented in the Federal Logistics Information System.